Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.41% is in line with its 5-year average of 4.23%, near the low end of its 5-year range (2.38%–10.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.54% below its 12-month average of 5.84%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.41%.
DEBT TO ASSETS RATIO
4.41%
DEBT TO ASSETS RATIO AVG TTM
5.84%
DEBT TO ASSETS RATIO AVG 3Y
3.94%
DEBT TO ASSETS RATIO AVG 5Y
4.23%
DEBT TO ASSETS RATIO AVG 10Y
4.56%
DEBT TO ASSETS RATIO AVG 15Y
13.35%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.54%
CURRENT VS 3Y AVG
+11.90%
CURRENT VS 5Y AVG
+4.23%
CURRENT VS 10Y AVG
-3.18%
CURRENT VS 15Y AVG
-66.97%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+4800.83%
vs the sector median at left
InspireMD, Inc.
Market Cap
$24.69M
Debt to Assets Ratio
4.41%
TTM Avg
5.84%
3Y Avg
3.94%
5Y Avg
4.23%
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.22M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.38M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.06M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.25M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.00M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $24.69M | 4.41% | 5.84% | 3.94% | 4.23% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.09% | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 0.00% | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 0.15% | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 0.00% | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.68M | 0.01% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.02% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 0.17% | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | 0.16% | N/A | N/A | N/A |
Debt/Assets
4.4%
Debt/Equity
0.06
Current Ratio
3.80
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.41% |
| 2026-03-31 | 5.51% |
| 2025-12-31 | 4.74% |
| 2025-09-30 | 4.30% |
| 2025-06-30 | 10.27% |
| 2025-03-31 | 6.00% |
| 2024-12-31 | 4.99% |
| 2024-09-30 | 2.43% |
| 2024-06-30 | 2.38% |
| 2024-03-31 | 3.48% |
| 2023-12-31 | 3.35% |
| 2023-09-30 | 3.12% |
| 2023-06-30 | 2.59% |
| 2023-03-31 | 7.52% |
| 2022-12-31 | 6.55% |
| 2022-09-30 | 5.98% |
| 2022-06-30 | 5.41% |
| 2022-03-31 | 3.10% |
| 2021-12-31 | 3.02% |
| 2021-09-30 | 2.92% |
| 2021-06-30 | 2.84% |
| 2021-03-31 | 2.62% |
| 2020-12-31 | 7.87% |
| 2020-09-30 | 8.16% |
| 2020-06-30 | 4.79% |
| 2020-03-31 | 12.34% |
| 2019-12-31 | 10.27% |
| 2019-09-30 | 9.04% |
| 2019-06-30 | 11.79% |
| 2019-03-31 | 11.32% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 28.48% |
| 2016-09-30 | 29.34% |
| 2016-06-30 | 129.77% |
| 2016-03-31 | 101.18% |
| 2015-12-31 | 92.30% |
| 2015-09-30 | 64.24% |
| 2015-06-30 | 52.90% |
| 2015-03-31 | 45.40% |
| 2014-12-31 | 77.62% |
| 2014-09-30 | 98.19% |
| 2014-06-30 | 71.09% |
| 2014-03-31 | 50.48% |
| 2013-09-30 | 41.75% |
| 2013-06-30 | 31.14% |
| 2013-03-31 | 75.38% |
| 2012-12-31 | 55.71% |
| 2012-09-30 | 41.39% |
| 2012-06-30 | 31.35% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.90% |
| 2011-09-30 | 1.52% |
| 2011-06-30 | 2.36% |
| 2011-03-31 | 11.41% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-06-30 | 0.00% |
